Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Marco R, de Groot"'
Autor:
Kirsten Geneugelijk, Kirsten A. Thus, Hanneke W. M. van Deutekom, Jorg J. A. Calis, Eric Borst, Can Keşmir, Machteld Oudshoorn, Bronno van der Holt, Ellen Meijer, Sacha Zeerleder, Marco R. de Groot, Peter A. von dem Borne, Nicolaas Schaap, Jan Cornelissen, Jürgen Kuball, Eric Spierings
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
HLA-mismatches in hematopoietic stem-cell transplantation are associated with an impaired overall survival (OS). The aim of this study is to explore whether the Predicted Indirectly ReCognizable HLA-Epitopes (PIRCHE) algorithm can be used to identify
Externí odkaz:
https://doaj.org/article/04efaf33c183496ba8c5a1597d27ee0a
Autor:
Arnon Nagler, Mohamad Mohty, Eliane Gluckman, Bipin N. Savani, Didier Blaise, Noel Milpied, Harry C. Schouten, Marco R. De Groot, Dietger Niederwieser, Henrik Sengeloev, Ellen Meijer, Jan J. Cornelissen, Annalisa Ruggeri, Myriam Labopin, Frédéric Baron
Purpose: We assessed the impact of donor type in acute myeloid leukemia (AML) patients transplanted with 2 Gy total body irradiation (TBI)-based nonmyeloablative conditioning regimen.Patients and Methods: Data from 1,715 adult patients, with AML in C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8631650a33b2bf4cc404c0a19523a550
https://doi.org/10.1158/1078-0432.c.6527607.v1
https://doi.org/10.1158/1078-0432.c.6527607.v1
Autor:
Anthony Lucci, Klaus Pantel, Sara Y. Brucker, Peter A. Fasching, Thomas W.P. Friedl, François-Clement Bidard, Marco R. de Groot, Carolyn Hall, Tanja Fehm, Florin-Andrei Taran, Jean-Yves Pierga, Leon W.M.M. Terstappen, Brigitte Rack, Wolfgang J. Janni
supplemental figure legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05562f1b88cf1e7921ff76ea3a274441
https://doi.org/10.1158/1078-0432.22459256
https://doi.org/10.1158/1078-0432.22459256
Autor:
Anthony Lucci, Klaus Pantel, Sara Y. Brucker, Peter A. Fasching, Thomas W.P. Friedl, François-Clement Bidard, Marco R. de Groot, Carolyn Hall, Tanja Fehm, Florin-Andrei Taran, Jean-Yves Pierga, Leon W.M.M. Terstappen, Brigitte Rack, Wolfgang J. Janni
Figure S1. Flow chart of the data selection process for a pooled analysis of the prognostic relevance of circulating tumor cells in early breast cancer. Patients were ineligible if no valid data on CTC presence at the time of primary diagnosis as ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c74f8b794ccb10191833472bae95c4
https://doi.org/10.1158/1078-0432.22459274.v1
https://doi.org/10.1158/1078-0432.22459274.v1
Autor:
Anthony Lucci, Klaus Pantel, Sara Y. Brucker, Peter A. Fasching, Thomas W.P. Friedl, François-Clement Bidard, Marco R. de Groot, Carolyn Hall, Tanja Fehm, Florin-Andrei Taran, Jean-Yves Pierga, Leon W.M.M. Terstappen, Brigitte Rack, Wolfgang J. Janni
Purpose: Although unequivocal evidence has shown the prognostic relevance of circulating tumor cells (CTC) in the peripheral blood of patients with metastatic breast cancer, less evidence is available for the prognostic relevance of CTCs at the time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4162a93fe63e1257cad59434c6890b5
https://doi.org/10.1158/1078-0432.c.6524183.v1
https://doi.org/10.1158/1078-0432.c.6524183.v1
Autor:
Anthony Lucci, Klaus Pantel, Sara Y. Brucker, Peter A. Fasching, Thomas W.P. Friedl, François-Clement Bidard, Marco R. de Groot, Carolyn Hall, Tanja Fehm, Florin-Andrei Taran, Jean-Yves Pierga, Leon W.M.M. Terstappen, Brigitte Rack, Wolfgang J. Janni
Table S1. Patients and study variables according to study center for the pooled analysis of circulating tumor cells in early breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b255db61f4471fa1496e101a93e90b7
https://doi.org/10.1158/1078-0432.22459259
https://doi.org/10.1158/1078-0432.22459259
Autor:
Carin L. E. Hazenberg, Aniek O. de Graaf, René Mulder, Laura B. Bungener, Maaike G. J. M. van Bergen, André B. Mulder, Goda Choi, Jan Jacob Schuringa, Marco R. de Groot, Edo Vellenga, Joop H. Jansen, Gerwin Huls, Isabelle A. van Zeventer
Publikováno v:
Blood Advances, 7, 7, pp. 1269-1278
Blood Advances, 7, 1269-1278
Blood Advances, 7, 1269-1278
Inadequate mobilization of peripheral blood progenitor cells (PBPCs) is a limiting factor to proceeding with autologous hematopoietic cell transplantation (auto-HCT). To assess the impact of clonal hematopoiesis (CH) on mobilization failure of PBPC f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9cef09038ef8a7a11c4f88f73739edc
Autor:
Gerard Dijkstra, Marijn C. Visschedijk, Remco J. Renken, Henk J. Buikema, Marco R. de Groot, Jacco J de Haan, Mathilde Jalving, Gursah Kats-Ugurlu, Sara Hone Lopez
Publikováno v:
Virchows Archiv
Virchows Archiv : an International Journal of Pathology, 479(6), 1119-1129. SPRINGER
Virchows Archiv : an International Journal of Pathology, 479(6), 1119-1129. SPRINGER
Colitis is a common, but poorly understood, adverse event of immune checkpoint inhibitors that are standard-of-care for an expanding range of cancer types. This explorative study aimed to describe the immune infiltrates in the colon from individuals
Autor:
Anton F.J. de Haan, Marco R. de Groot, Nicole N.M. Blijlevens, Gerwin Huls, Andre B. Mulder, Marjan Cruijsen, Nicolaas Schaap, Joop H. Jansen, Edo Vellenga, B. Bär, Frédéric Baron, Walter J.F.M. van der Velden, Jacobien R. Hilberink
Publikováno v:
Bone Marrow Transplantation, 56, 8, pp. 1964-1970
Bone marrow transplantation, 56(8), 1964-1970. Nature Publishing Group
Bone Marrow Transplantation, 56, 1964-1970
Bone marrow transplantation, 56(8), 1964-1970. Nature Publishing Group
Bone Marrow Transplantation, 56, 1964-1970
Contains fulltext : 237746.pdf (Publisher’s version ) (Closed access) Patients with poor risk acute myeloid leukemia (AML) have a dismal outcome. We hypothesized that combining decitabine with a standard non-myeloablative (NMA) conditioning regimen
Autor:
Annoek E. C. Broers, Cornelis N. de Jong, Katerina Bakunina, Mette D. Hazenberg, Marinus van Marwijk Kooy, Marco R. de Groot, Michel van Gelder, Jürgen Kuball, Bronno van der Holt, Ellen Meijer, Jan J. Cornelissen
Publikováno v:
Blood advances, 6(11), 3378-3385. The American Society of Hematology
HOVON Stem Cell Transplantation Working Group 2022, ' Posttransplant cyclophosphamide for prevention of graft-versus-host disease : results of the prospective randomized HOVON-96 trial ', Blood, vol. 6, no. 11, pp. 3378-3385 . https://doi.org/10.1182/bloodadvances.2021005847
Blood, 6(11), 3378-3385. American Society of Hematology
Blood Advances, 6(11), 3378-3385. AMER SOC HEMATOLOGY
Blood advances, 6(11), 3378-3385. American Society of Hematology
HOVON Stem Cell Transplantation Working Group 2022, ' Posttransplant cyclophosphamide for prevention of graft-versus-host disease : results of the prospective randomized HOVON-96 trial ', Blood, vol. 6, no. 11, pp. 3378-3385 . https://doi.org/10.1182/bloodadvances.2021005847
Blood, 6(11), 3378-3385. American Society of Hematology
Blood Advances, 6(11), 3378-3385. AMER SOC HEMATOLOGY
Blood advances, 6(11), 3378-3385. American Society of Hematology
Graft-versus-host disease (GVHD) is the most important complication of allogeneic hematopoietic stem cell transplantation (alloHSCT). We performed a prospective randomized, multicenter, phase 3 trial to study whether posttransplant cyclophosphamide (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32996818b6d9a28257235f7969d0bfe9
https://cris.maastrichtuniversity.nl/en/publications/c7c230b3-1333-4c7e-aa88-350cf123e605
https://cris.maastrichtuniversity.nl/en/publications/c7c230b3-1333-4c7e-aa88-350cf123e605